These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14523905)

  • 1. [Diabetes mellitus].
    Bosi E
    G Ital Nefrol; 2003; 20 Suppl 25():S3-6. PubMed ID: 14523905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The natural history of diabetes with respect to disorders of insulin function].
    Dorner M; Pinget M; Brogard JM; Sapin R; Paris-Bockel D; Levy P; Jung C
    Journ Annu Diabetol Hotel Dieu; 1984; ():51-71. PubMed ID: 6399540
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
    Evans AJ; Krentz AJ
    Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes nomenclature: classification or grading of severity?
    Turner RC; Holman RR; Matthews DR; O'Rahilly SP; Rudenski AS; Braund WJ
    Diabet Med; 1986 May; 3(3):216-20. PubMed ID: 2951172
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta- and alpha-cell dysfunction in type 2 diabetes.
    Del Prato S; Marchetti P
    Horm Metab Res; 2004; 36(11-12):775-81. PubMed ID: 15655708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes.
    Farret A; Lugo-Garcia L; Galtier F; Gross R; Petit P
    Fundam Clin Pharmacol; 2005 Dec; 19(6):647-56. PubMed ID: 16313276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, classification, and pathogenesis of diabetes mellitus.
    Lebovitz HE
    J Clin Psychiatry; 2001; 62 Suppl 27():5-9; discussion 40-1. PubMed ID: 11806489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin.
    Chan JL; Abrahamson MJ
    Mayo Clin Proc; 2003 Apr; 78(4):459-67. PubMed ID: 12683698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
    Reaven GM
    Diabetes Care; 1984; 7 Suppl 1():17-24. PubMed ID: 6376025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta cell failure: causes and consequences.
    Kahn SE
    Int J Clin Pract Suppl; 2001 Sep; (123):13-8. PubMed ID: 11594291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential type 2 diabetes therapy based on pathophysiological aspects].
    Hanefeld M; Fischer S
    Ther Umsch; 2002 Aug; 59(8):393-401. PubMed ID: 12235731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-insulin-dependent diabetes mellitus: a clinical strategy.
    Skyler JS
    Diabetes Care; 1984; 7 Suppl 1():118-29. PubMed ID: 6376024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and hypertension physiopathology and therapeutics.
    Contreras F; Rivera M; Vasquez J; De la Parte MA; Velasco M
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S26-31. PubMed ID: 10854077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
    Baretić M; Troskot R
    Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes; 1995 Nov; 44(11):1249-58. PubMed ID: 7589820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present condition and future prospects in diagnosis of and therapy for diabetes mellitus].
    Seino Y
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):713-6. PubMed ID: 19469089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.